Skip to main content

Cingulate Inc.

CINGW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001862150

No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.88K in total; no superinvestor holds it.

Other share classesCING

Q1 2024 vs. Q4 2023

How the institutions holding Cingulate Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CINGW: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders880
Shares1.54M1.02M−527.4K (−34.2%)
Value$34.6K$18.8K−$15.9K (−45.8%)

New holders (0)

Institutions that held Cingulate Inc. at the end of Q1 2024 but not at the end of Q4 2023.

None.

Sold out (0)

Institutions that held Cingulate Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

None.